Serveur d'exploration sur le lymphœdème - Checkpoint (Ncbi)

Index « Auteurs » - entrée « Mark J. Taylor »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Mark J. Stavas < Mark J. Taylor < Mark J. Van Der Laan  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000318 (2000) Mark J. Taylor [Royaume-Uni] ; Helen F. Cross [Royaume-Uni] ; Katja Bilo [Royaume-Uni]Inflammatory Responses Induced by the Filarial Nematode Brugia malayi Are Mediated by Lipopolysaccharide-like Activity from Endosymbiotic Wolbachia Bacteria
000E06 (2003) Mark J. Taylor [Royaume-Uni]Wolbachia in the inflammatory pathogenesis of human filariasis.
001731 (2003) David H. Molyneux [Royaume-Uni] ; Mark Bradley ; Achim Hoerauf ; Dominique Kyelem ; Mark J. TaylorMass drug treatment for lymphatic filariasis and onchocerciasis.
001744 (2003) William H. Makunde [Tanzanie] ; Leo M. Kamugisha [Tanzanie] ; Julius J. Massaga [Tanzanie] ; Rachel W. Makunde [Tanzanie] ; Zakana X. Savael [Tanzanie] ; Juma Akida [Tanzanie] ; Fred M. Salum [Tanzanie] ; Mark J. Taylor [Royaume-Uni]Treatment of co-infection with bancroftian filariasis and onchocerciasis: a safety and efficacy study of albendazole with ivermectin compared to treatment of single infection with bancroftian filariasis
001E71 (????) Mark J. Taylor [Royaume-Uni] ; Williams H. Makunde ; Helen F. Mcgarry ; Joseph D. Turner ; Sabine Mand ; Achim HoeraufMacrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomised placebo-controlled trial.
002C66 (2008) Taniawati Supali [Indonésie] ; Yenny Djuardi ; Kenneth M. Pfarr ; Heri Wibowo ; Mark J. Taylor ; Achim Hoerauf ; Jeanine J. Houwing-Duistermaat ; M. Yazdanbakhsh ; Erliyani SartonoDoxycycline treatment of Brugia malayi-infected persons reduces microfilaremia and adverse reactions after diethylcarbamazine and albendazole treatment.
003419 (2009) Joseph D. Turner ; R. Stuart Langley ; Kelly L. Johnston ; Katrin Gentil ; Louise Ford ; Bo Wu [États-Unis] ; Maia Graham ; Faye Sharpley ; Barton Slatko [États-Unis] ; Eric Pearlman ; Mark J. TaylorWolbachia Lipoprotein Stimulates Innate and Adaptive Immunity through Toll-like Receptors 2 and 6 to Induce Disease Manifestations of Filariasis*
003436 (2009) Moses J. Bockarie [Royaume-Uni] ; Mark J. Taylor ; John O. GyapongCurrent practices in the management of lymphatic filariasis.
003D26 (2010) Mark J. Taylor [Royaume-Uni] ; Achim Hoerauf ; Moses BockarieLymphatic filariasis and onchocerciasis.
003E84 (2010) Kelly L. Johnston [Royaume-Uni] ; Bo Wu [États-Unis] ; Ana Guimarães [Royaume-Uni] ; Louise Ford [Royaume-Uni] ; Barton E. Slatko [États-Unis] ; Mark J. Taylor [Royaume-Uni]Lipoprotein biosynthesis as a target for anti-Wolbachia treatment of filarial nematodes
005395 (2012) Frédéric Landmann [États-Unis] ; Odile Bain [France] ; Coralie Martin [France] ; Shigehiko Uni [Malaisie] ; Mark J. Taylor [Royaume-Uni] ; William Sullivan [États-Unis]Both asymmetric mitotic segregation and cell-to-cell invasion are required for stable germline transmission of Wolbachia in filarial nematodes
005B50 (2013) Mark J. Taylor [Royaume-Uni] ; Achim Hoerauf [Allemagne] ; Simon Townson [Royaume-Uni] ; Barton E. Slatko [États-Unis] ; Stephen A. Ward [Royaume-Uni]Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis
005F49 (2014) Kelly L. Johnston [Royaume-Uni] ; Louise Ford ; Mark J. TaylorOvercoming the challenges of drug discovery for neglected tropical diseases: the A·WOL experience.
006B67 (2015) Rachel H. Clare [Royaume-Uni] ; Darren A N. Cook [Royaume-Uni] ; Kelly L. Johnston [Royaume-Uni] ; Louise Ford [Royaume-Uni] ; Stephen A. Ward [Royaume-Uni] ; Mark J. Taylor [Royaume-Uni]Development and validation of a high-throughput anti-Wolbachia whole-cell screen: a route to macrofilaricidal drugs against onchocerciasis and lymphatic filariasis.
006C49 (2014) Alice Halliday [Royaume-Uni] ; Ana F. Guimaraes [Royaume-Uni] ; Hayley E. Tyrer [Royaume-Uni] ; Haelly Mejane Metuge [Cameroun] ; Chounna Ndongmo Winston Patrick [Cameroun] ; Kengne-Ouafo Jonas Arnaud [Cameroun] ; Tayong Dizzle Bita Kwenti [Cameroun] ; George Forsbrook [Royaume-Uni] ; Andrew Steven [Royaume-Uni] ; Darren Cook [Royaume-Uni] ; Peter Enyong [Cameroun] ; Samuel Wanji [Cameroun] ; Mark J. Taylor [Royaume-Uni] ; Joseph D. Turner [Royaume-Uni]A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis
006E81 (2014) Martin Walker [Royaume-Uni] ; Sabine Specht [Allemagne] ; Thomas S. Churcher [Royaume-Uni] ; Achim Hoerauf [Allemagne] ; Mark J. Taylor [Royaume-Uni] ; María-Gloria Basá Ez [Royaume-Uni]Therapeutic Efficacy and Macrofilaricidal Activity of Doxycycline for the Treatment of River Blindness
008072 (2016) Raman Sharma [Royaume-Uni] ; Ghaith Al Jayoussi [Royaume-Uni] ; Hayley E. Tyrer [Royaume-Uni] ; Joanne Gamble [Royaume-Uni] ; Laura Hayward [Royaume-Uni] ; Ana F. Guimaraes [Royaume-Uni] ; Jill Davies [Royaume-Uni] ; David Waterhouse [Royaume-Uni] ; Darren A. N. Cook [Royaume-Uni] ; Laura J. Myhill [Royaume-Uni] ; Rachel H. Clare [Royaume-Uni] ; Andrew Cassidy [Royaume-Uni] ; Andrew Steven [Royaume-Uni] ; Kelly L. Johnston [Royaume-Uni] ; Louise Ford [Royaume-Uni] ; Joseph D. Turner [Royaume-Uni] ; Stephen A. Ward [Royaume-Uni] ; Mark J. Taylor [Royaume-Uni]Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasis
008E61 (2017) Ghaith Aljayyoussi ; Hayley E. Tyrer ; Louise Ford ; Hanna Sjoberg ; Nicolas Pionnier ; David Waterhouse ; Jill Davies ; Joanne Gamble ; Haelly Metugene [Cameroun] ; Darren A. N. Cook ; Andrew Steven ; Raman Sharma ; Ana F. Guimaraes ; Rachel H. Clare ; Andrew Cassidy ; Kelly L. Johnston ; Laura Myhill ; Laura Hayward ; Samuel Wanji [Cameroun] ; Joseph D. Turner ; Mark J. Taylor ; Stephen A. WardShort-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "Mark J. Taylor" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "Mark J. Taylor" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Mark J. Taylor
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024